Harvard Bioscience, Inc. (HBIO)
NASDAQ: HBIO · Real-Time Price · USD
0.550
-0.021 (-3.68%)
At close: Mar 6, 2026, 4:00 PM EST
0.495
-0.055 (-10.05%)
After-hours: Mar 6, 2026, 7:57 PM EST
Harvard Bioscience Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Harvard Bioscience stock have an average target of 2.50, with a low estimate of 2.00 and a high estimate of 3.00. The average target predicts an increase of 354.55% from the current stock price of 0.55.
Analyst Consensus: Buy
* Price targets were last updated on Sep 10, 2025.
Analyst Ratings
The average analyst rating for Harvard Bioscience stock from 3 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Benchmark | Benchmark | Buy Maintains $3 → $2 | Buy | Maintains | $3 → $2 | +263.64% | Sep 10, 2025 |
| Benchmark | Benchmark | Buy Maintains $4.5 → $3 | Buy | Maintains | $4.5 → $3 | +445.45% | May 13, 2025 |
| Keybanc | Keybanc | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Apr 9, 2025 |
| Benchmark | Benchmark | Buy Maintains $5.5 → $4.5 | Buy | Maintains | $5.5 → $4.5 | +718.18% | Mar 24, 2025 |
| Benchmark | Benchmark | Buy Reiterates $7 | Buy | Reiterates | $7 | +1,172.73% | Jun 22, 2023 |
Financial Forecast
Revenue This Year
87.62M
from 94.14M
Decreased by -6.92%
Revenue Next Year
94.45M
from 87.62M
Increased by 7.80%
EPS This Year
0.03
from -0.28
EPS Next Year
0.10
from 0.03
Increased by 216.67%
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 90.5M | 100.4M | |
| Avg | 87.6M | 94.5M | |
| Low | 83.9M | 87.8M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -3.9% | 14.6% | |
| Avg | -6.9% | 7.8% | |
| Low | -10.9% | 0.2% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 0.04 | 0.14 | |
| Avg | 0.03 | 0.10 | |
| Low | 0.02 | 0.06 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | 346.1% | |
| Avg | - | 216.7% | |
| Low | - | 92.2% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.